Navigation Links
Quorum Review IRB Presents “IRB Review of Registries, Databases and Biobanking” at 2013 AAHRPP Conference
Date:3/21/2013

Seattle, WA (PRWEB) March 21, 2013

Quorum Review IRB, the industry leader in central IRB services, announces CEO Cami Gearhart, JD, as a featured presenter at the upcoming Association for the Accreditation of Human Research Protection Programs (AAHRPP) International Conference held in Miami, FL, on Friday, April 5th, 2013.

Ms. Gearhart’s presentation, “IRB Review of Registries, Databases and Biobanking,” focuses on the regulatory considerations involved with the collection, storage, and distribution of human biological specimens used in clinical research. Gearhart’s presentation covers an introduction to bio-repositories, the regulatory statutes and related guidance defining IRB review, as well as considerations when submitting such research for IRB review.

Ms. Gearhart originally joined Quorum Review as a member of the IRB, and was appointed CEO in 2006. She has led the Quorum business through two AAHRPP accreditations and a successful expansion into Canada. Prior to joining Quorum Review, Ms. Gearhart practiced law in both the private sector, specializing in health care regulatory law for hospitals, clinics and other institutions, and the public sector, working for the Office of Attorney General protecting vulnerable populations. Ms. Gearhart also serves as Treasurer of the Consortium of Institutional Review Boards and Vice President for the Northwest Association for Biomedical Research’s Board of Directors.

The 2013 AAHRPP Conference offers programs that support AAHRPP’s mission of promoting high-quality clinical research and human research protection through its accreditation programs. More information about the 2013 conference is available on the AAHRPP website.
For the latest on Quorum Review News and Events, visit http://www.quorumreview.com.

About Quorum Review

Quorum Review is an independent institutional review board fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP), and has been providing IRB review of drug and device trials since 1992. Quorum oversees research in accordance with U.S. and Canadian human subject research protection regulations and guidelines set forth by the International Committee on Harmonisation (ICH), and principles of the Belmont Report.

Quorum’s best-in-class IRB services include 14 Board meetings each week plus expedited review, 24-hour site review turnaround, 36-hour amendment review turnaround, a secure web portal, and Smart Forms for online submissions. Quorum’s IRB service offerings include full study review in the US and Canada, a specialized Phase I team, and unique processes for post-approval and registry studies.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10549910.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Quorum Review IRB Launches Site Enrollment Service
2. Omega-3 Supplements No Help Against Repeat Heart Trouble: Review
3. AADR comments on review that validates association between oral health and heart health
4. IUDs Work as Emergency Contraceptive: Review
5. ICU stays for worst asthma drop 74 percent, review finds
6. Antiretroviral treatment for preventing HIV infection: an evidence review for physicians
7. TheBestHeartRateMonitorReviews.com Announces The Top 3 Heart Rate Monitors
8. US Drug Watchdog Now Offers To Get A Free Legal Review For All DePuy ASR Recipients Who Received A Letter From Broadspire About Their Recalled DePuy Hip Implant
9. University of Nevada School of Medicine researcher reviews muscular dystrophy therapies
10. Metabolic Cooking Review For Karine Losier and Dave Ruel's Diet And Cookbook Program Released
11. Waterpik Water Flosser Reviews Released Today By WaterpikReviews.net
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... 2017 , ... Contrary to popular perception, a new study ... noteworthy rates. Between 2002 and 2014, Salas-Wright and his colleagues found a 29% ... United States. The study, Trends in Fighting and Violence Among Adolescents in ...
(Date:4/21/2017)... ... ... Dudnyk has announced the launch of its new brand identity, called The ... specialty and orphan brands can only be achieved when the needs and beliefs of ... at the heart of a true partnership between our agency and our clients to ...
(Date:4/21/2017)... (PRWEB) , ... April 21, 2017 , ... ... performance system, has partnered with O2X , an active lifestyle company that ... on improving the health of firefighters, police offers, first responders, military officers and ...
(Date:4/21/2017)... ... April 21, 2017 , ... Metrasens is honoured ... Trade, the UK’s most prestigious award for business success. The company has ... revenues and has grown by a total of 400% over the last six ...
(Date:4/21/2017)... Abilene, Texas (PRWEB) , ... April 21, 2017 , ... Yisrayl Hawkins, Pastor and Overseer ... out to world leaders in hopes of squashing a global crisis with solution to peace ... is guaranteed to work because the plan is given by the Creator Himself. , ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)...  Sorrento Therapeutics, Inc. (NASDAQ: SRNE ... new treatments for cancer and other unmet medical ... announced underwritten public offering of 23,625,084 shares of ... of $2.00 per share, before deducting underwriting discounts ... Sorrento.  The net proceeds to Sorrento from this ...
(Date:4/18/2017)... Ohio , April 18, 2017  Cardinal Health ... Non-GAAP 1 fiscal 2017 earnings per share (EPS) ... and 2019.  This is in conjunction with this morning,s ... Deep Vein Thrombosis and Nutritional Insufficiency businesses. ... from continuing operations will be at the bottom of ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, 2017 ... ) ("Imprimis"), an ophthalmology-focused pharmaceutical company, and Cameron ... announced the signing of a three-year exclusive sales ... deploy a dedicated sales team to introduce Imprimis, ... primarily focused in 13 states in the U.S. ...
Breaking Medicine Technology: